WA

Waseem Akhtar

Active Director Director DIN 09860361
DIN 09860361 First appointment Jan 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Waseem Akhtar

Data last updated:

Waseem Akhtar is a Director at Stalline Biotech Private Limited (since 2023). The company operates in Chemicals. Stalline Biotech Private Limited reported revenue of ₹2.62 Cr (FY 2024).

DIN 09860361
Primary Designation Director
Industry Chemicals
First Appointment 13 Jan 2023
Oldest Company Age 3 yrs
Largest company Stalline Biotech Private Limited · ₹2.62 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stalline Biotech Private Limited U24239UP2023PTC177017
Director13 Jan 20232023₹2.62 Cr (FY 2024)Active

Board colleagues of Waseem Akhtar

NameDINCompanyDesignation
Amaan Waseem09860360Stalline Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Stalline Biotech Private Limited
Premium access

Shareholding and investment profile for Waseem Akhtar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Waseem Akhtar

Waseem Akhtar currently holds 1 directorship: Stalline Biotech Private Limited (Director, since 13 Jan 2023, revenue ₹2.62 Cr (FY 2024)).

Waseem Akhtar was first appointed on 13 Jan 2023 as Director at Stalline Biotech Private Limited.

The current boards of Waseem Akhtar's companies include Amaan Waseem (Stalline Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available